Skip to main content
Premium Trial:

Request an Annual Quote

Plexpress, MediSapiens Ink Gene Express Data Analysis Deal

NEW YORK (GenomeWeb News) – Plexpress today said that it has teamed up with MediSapiens to offer a new gene expression service that combines the firms' technologies.

Under the alliance, MediSapiens' IST Online Gene Expression Database had been combined with Plexpress' TRAC platform for high-throughput gene expression analysis. The firms said that they have launched the resulting OncoTrac Gene Expression Service, providing a "complete solution" from gene discovery and validation to studies across biomarker discovery, drug development, and life science research applications.

Plexpress CEO Jari Rautio said in a statement that the TRAC technology is ideal for use after genomic discovery with the MediSapiens database, which contains more than 20,000 samples and 300 million data points. The TRAC technology enables multiplex analysis of up to 30 genes in hundreds to thousands of samples. "In this way, researchers can really investigate the biology of their system in considerable depth, without sacrificing the number of genes they can assay in each sample," Rautio added.

Helsinki, Finland-based Plexpress is a spinoff of the Finnish Technology Research Center. MediSapiens, also based in Helsinki, specializes in cloud computing and genomic data mining and claims that its IST Online Gene Expression viewer is the world's largest unified gene expression database.

Financial and other terms of the alliance were not disclosed.